CA Patent

CA2945705A1 — Methods for treating hypersomnia

Assigned to BALANCE THERAPEUTICS Inc · Expires 2015-10-22 · 11y expired

What this patent protects

Provided herein are methods, formulations and dosing regimens for treating hypersomnia in a subject. For instance, methods provided herein comprise administering a GABAA chloride channel blocker. In certain embodiments, the GABAA chloride channel blocker is pentylenetetrazol (PTZ…

USPTO Abstract

Provided herein are methods, formulations and dosing regimens for treating hypersomnia in a subject. For instance, methods provided herein comprise administering a GABAA chloride channel blocker. In certain embodiments, the GABAA chloride channel blocker is pentylenetetrazol (PTZ).

Drugs covered by this patent

Patent Metadata

Patent number
CA2945705A1
Jurisdiction
CA
Classification
—
Expires
2015-10-22
Drug substance claim
No
Drug product claim
No
Assignee
BALANCE THERAPEUTICS Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.